Abstract Details

Title More Alemtuzumab Relapsing-Remitting Multiple Sclerosis Patients Are Free of Clinical Disease Activity at Five Years

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 003

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Cary L. Twyman, MD, FAAN (PennState Health Milton S. Hershey Medical Center)	No disclosure on file
	No disclosure on file
Matthew Klein	Matthew Klein has received personal compensation for serving as an employee of PTC Therapeutics. Matthew Klein has stock in PTC Therapeutics. Matthew Klein has received publishing royalties from a publication relating to health care.

��ɫ��